Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery.
暂无分享,去创建一个
Shengrong Guo | Feihu Wang | Shengrong Guo | Feihu Wang | Yun Wang | Xiao Zhang | Wenjun Zhang | Fang Jin | Wenjun Zhang | Yun Wang | Xiao Zhang | Fang Jin
[1] Christopher J. Cheng,et al. Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides. , 2011, Biomaterials.
[2] M. Dec,et al. Antimicrobial activity of , 2016 .
[3] Jim Euchner. Design , 2014, Catalysis from A to Z.
[4] S. Futaki,et al. Cell-penetrating peptides (CPPs) as a vector for the delivery of siRNAs into cells. , 2013, Molecular bioSystems.
[5] C. Joe,et al. Folate receptor-mediated intracellular delivery of recombinant caspase-3 for inducing apoptosis. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[6] Scott Banta,et al. An unusual cell penetrating peptide identified using a plasmid display-based functional selection platform. , 2011, ACS chemical biology.
[7] C. I. Smith,et al. Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and their stability in simulated gastric conditions , 2012, Journal of Controlled Release.
[8] Ulo Langel,et al. Cell-penetrating peptides: mechanism and kinetics of cargo delivery. , 2005, Advanced drug delivery reviews.
[9] T. Kissel,et al. Integrin targeting using RGD‐PEI conjugates for in vitro gene transfer , 2003, The journal of gene medicine.
[10] David Piwnica-Worms,et al. Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model , 2009, Proceedings of the National Academy of Sciences.
[11] T. Park,et al. RGD targeting hyaluronic acid coating system for PEI-PBLG polycation gene carriers. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[12] G. Wong,et al. Arginine‐rich cell‐penetrating peptides , 2010, FEBS letters.
[13] H. Chen,et al. The nuclear localization signal sequence of porcine circovirus type 2 ORF2 enhances intracellular delivery of plasmid DNA , 2011, Archives of Virology.
[14] J. Chmielewski,et al. Cationic Amphiphilic Polyproline Helices: Side‐Chain Variations and Cell‐Specific Internalization , 2009, Chemical Biology and Drug Design.
[15] J. Ochocki,et al. Evaluation of a cell penetrating prenylated peptide lacking an intrinsic fluorophore via in situ click reaction. , 2011, Bioorganic & medicinal chemistry letters.
[16] P. Boisguérin,et al. Comparison of cellular uptake using 22 CPPs in 4 different cell lines. , 2008, Bioconjugate chemistry.
[17] B. Lebleu,et al. Cellular Uptake of Unconjugated TAT Peptide Involves Clathrin-dependent Endocytosis and Heparan Sulfate Receptors* , 2005, Journal of Biological Chemistry.
[18] M. Ferrer,et al. Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides. , 2005, Biochimica et biophysica acta.
[19] Ű. Langel,et al. Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery. , 2006, Current opinion in pharmacology.
[20] James F. Leary,et al. Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy. , 2012, Biomaterials.
[21] Donald M. O'Rourke,et al. Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivo , 2000, Nature Biotechnology.
[22] Ű. Langel,et al. N-terminal peptides from unprocessed prion proteins enter cells by macropinocytosis. , 2006, Biochemical and biophysical research communications.
[23] R. Stern. Hyaluronidases in cancer biology. , 2008, Seminars in cancer biology.
[24] Jun Yao,et al. Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide. , 2006, Cancer research.
[25] Simon W. Jones,et al. Characterisation of cell‐penetrating peptide‐mediated peptide delivery , 2005, British journal of pharmacology.
[26] Kyung-Soo Hahm,et al. Antimicrobial activity, bactericidal mechanism and LPS‐neutralizing activity of the cell‐penetrating peptide pVEC and its analogs , 2011, Journal of peptide science : an official publication of the European Peptide Society.
[27] Irene Martín,et al. Design, Synthesis and Characterization of a New Anionic Cell‐Penetrating Peptide: SAP(E) , 2011, Chembiochem : a European journal of chemical biology.
[28] S. Futaki,et al. Arginine-rich peptides and their internalization mechanisms. , 2007, Biochemical Society transactions.
[29] Iqbal Massodi,et al. Application of Thermally Responsive Elastin-like Polypeptide Fused to a Lactoferrin-derived Peptide for Treatment of Pancreatic Cancer , 2009, Molecules.
[30] Yue-Wern Huang,et al. Mechanistic studies of intracellular delivery of proteins by cell-penetrating peptides in cyanobacteria , 2013, BMC Microbiology.
[31] R. Tsien,et al. In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity. , 2012, Integrative biology : quantitative biosciences from nano to macro.
[32] M. Morris,et al. Cell‐penetrating peptides: from molecular mechanisms to therapeutics , 2008, Biology of the cell.
[33] Sei Kwang Hahn,et al. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex. , 2011, ACS nano.
[34] Shana O Kelley,et al. Recent advances in the use of cell-penetrating peptides for medical and biological applications. , 2009, Advanced drug delivery reviews.
[35] A. Eguchi,et al. siRNA delivery using peptide transduction domains. , 2009, Trends in pharmacological sciences.
[36] G. W. Vuister,et al. A Cell-penetrating Peptide Derived from Human Lactoferrin with Conformation-dependent Uptake Efficiency , 2009, The Journal of Biological Chemistry.
[37] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.
[38] Y. Yoshioka,et al. Improved cytosolic translocation and tumor-killing activity of Tat-shepherdin conjugates mediated by co-treatment with Tat-fused endosome-disruptive HA2 peptide. , 2007, Biochemical and biophysical research communications.
[39] C. le Grimellec,et al. Primary amphipathic cell-penetrating peptides: structural requirements and interactions with model membranes. , 2004, Biochemistry.
[40] M. Mano,et al. S4(13)-PV cell-penetrating peptide forms nanoparticle-like structures to gain entry into cells. , 2010, Bioconjugate chemistry.
[41] Ű. Langel,et al. Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide. , 2006, Biochemical pharmacology.
[42] M. Akashi,et al. Fibroblast Growth Factor-12 (FGF12) Translocation into Intestinal Epithelial Cells Is Dependent on a Novel Cell-penetrating Peptide Domain , 2011, The Journal of Biological Chemistry.
[43] Robert Langer,et al. Targeted nanoparticles for cancer therapy , 2007 .
[44] D. Raucher,et al. A thermally responsive Tat-elastin-like polypeptide fusion protein induces membrane leakage, apoptosis, and cell death in human breast cancer cells* , 2007, Journal of drug targeting.
[45] Tianyue Jiang,et al. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery. , 2012, Biomaterials.
[46] G. Tang,et al. Gene delivery to tumor cells by cationic polymeric nanovectors coupled to folic acid and the cell-penetrating peptide octaarginine. , 2011, Biomaterials.
[47] E. Giralt,et al. Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gamma-zein. , 2004, Angewandte Chemie.
[48] M. Hong,et al. Asymmetric insertion of membrane proteins in lipid bilayers by solid-state NMR paramagnetic relaxation enhancement: a cell-penetrating Peptide example. , 2008, Journal of the American Chemical Society.
[49] R. Vandenbroucke,et al. Cellular entry pathway and gene transfer capacity of TAT-modified lipoplexes. , 2007, Biochimica et biophysica acta.
[50] S. Futaki,et al. Cell-surface accumulation of flock house virus-derived peptide leads to efficient internalization via macropinocytosis. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[51] J. Rothbard,et al. Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation , 2000, Nature Medicine.
[52] Ü. Langel,et al. Delivery of short interfering RNA using endosomolytic cell‐penetrating peptides , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[53] Joel A. Cohen,et al. Enhanced cell penetration of acid-degradable particles functionalized with cell-penetrating peptides. , 2008, Bioconjugate chemistry.
[54] Henrik J Johansson,et al. Characterization of a Novel Cytotoxic Cell-penetrating Peptide Derived From p14ARF Protein. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[55] Yasuyoshi Watanabe,et al. Molecular imaging analysis of intestinal insulin absorption boosted by cell-penetrating peptides by using positron emission tomography. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[56] Kurt Ballmer-Hofer,et al. Antennapedia and HIV Transactivator of Transcription (TAT) “Protein Transduction Domains” Promote Endocytosis of High Molecular Weight Cargo upon Binding to Cell Surface Glycosaminoglycans* , 2003, Journal of Biological Chemistry.
[57] S. Futaki,et al. Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides. , 2008, Advanced drug delivery reviews.
[58] S. Futaki,et al. Delivery of Macromolecules Using Arginine-Rich Cell-Penetrating Peptides: Ways to Overcome Endosomal Entrapment , 2009, The AAPS Journal.
[59] Glenn Walter,et al. Rapid and effective labeling of brain tissue using TAT-conjugated CdS:Mn/ZnS quantum dots. , 2005, Chemical communications.
[60] R. Artero,et al. A conserved motif controls nuclear localization of Drosophila Muscleblind , 2010, Molecules and cells.
[61] S. Futaki,et al. Cellular uptake, distribution and cytotoxicity of the hydrophobic cell penetrating peptide sequence PFVYLI linked to the proapoptotic domain peptide PAD. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[62] C. Beattie,et al. Noncationic peptides obtained from azurin preferentially enter cancer cells. , 2009, Cancer research.
[63] André Pèlegrin,et al. Cell-penetrating and cell-targeting peptides in drug delivery. , 2008, Biochimica et biophysica acta.
[64] Satyajit Mayor,et al. Pathways of clathrin-independent endocytosis , 2007, Nature Reviews Molecular Cell Biology.
[65] Ick Chan Kwon,et al. Self-assembled hyaluronic acid nanoparticles for active tumor targeting. , 2010, Biomaterials.
[66] T. Tarragó,et al. all-D proline-rich cell-penetrating peptides: a preliminary in vivo internalization study. , 2007, Biochemical Society transactions.
[67] Yue-Wern Huang,et al. Intracellular delivery of quantum dots mediated by a histidine- and arginine-rich HR9 cell-penetrating peptide through the direct membrane translocation mechanism. , 2011, Biomaterials.
[68] I. Mäger,et al. In vivo biodistribution and efficacy of peptide mediated delivery. , 2010, Trends in pharmacological sciences.
[69] Miriam Scadeng,et al. Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival , 2010, Proceedings of the National Academy of Sciences.
[70] P. Iversen,et al. Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure–activity studies , 2008, Nucleic acids research.
[71] B. Wiesner,et al. Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. , 1998, Biochimica et biophysica acta.
[72] L. Khachigian,et al. Nuclear import of early growth response-1 involves importin-7 and the novel nuclear localization signal serine-proline-serine. , 2011, The international journal of biochemistry & cell biology.
[73] J. M. Kumar,et al. Targeting human epidermal growth factor receptor 2 by a cell-penetrating peptide-affibody bioconjugate. , 2012, Biomaterials.
[74] Roger Y Tsien,et al. Tumor imaging by means of proteolytic activation of cell-penetrating peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[75] G. Divita,et al. Direct Translocation as Major Cellular Uptake for CADY Self-Assembling Peptide-Based Nanoparticles , 2011, PloS one.
[76] M. Morris,et al. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. , 2008, Advanced drug delivery reviews.
[77] M. Pooga,et al. Cell-penetrating Peptides Split into Two Groups Based on Modulation of Intracellular Calcium Concentration* , 2012, The Journal of Biological Chemistry.
[78] Ralph Weissleder,et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.
[79] T. Allen. Ligand-targeted therapeutics in anticancer therapy , 2002, Nature Reviews Cancer.
[80] Christoph Patsch,et al. The FASEB Journal Research Communication Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells , 2022 .
[81] Azam Bolhassani,et al. Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer. , 2011, Biochimica et biophysica acta.
[82] K. Doh,et al. Homodimeric SV40 NLS peptide formed by disulfide bond as enhancer for gene delivery. , 2012, Bioorganic & medicinal chemistry letters.
[83] M. Rhee,et al. Mechanism of Uptake of C105Y, a Novel Cell-penetrating Peptide* , 2006, Journal of Biological Chemistry.
[84] Yongzhuo Huang,et al. TAT-modified nanosilver for combating multidrug-resistant cancer. , 2012, Biomaterials.
[85] R. Tsien,et al. Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases , 2010, Proceedings of the National Academy of Sciences.
[86] J. J. Nestor,et al. The medicinal chemistry of peptides. , 2009, Current medicinal chemistry.
[87] M. Benincasa,et al. Dual mode of action of Bac7, a proline-rich antibacterial peptide. , 2006, Biochimica et biophysica acta.
[88] Dihua Yu,et al. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. , 1997, Cancer research.
[89] Astrid Gräslund,et al. Mechanisms of Cellular Uptake of Cell-Penetrating Peptides , 2011, Journal of biophysics.
[90] Tae Gwan Park,et al. Thermally triggered cellular uptake of quantum dots immobilized with poly(N-isopropylacrylamide) and cell penetrating peptide. , 2010, Langmuir : the ACS journal of surfaces and colloids.
[91] Yue-Wern Huang,et al. Delivery of Nucleic Acids, Proteins, and Nanoparticles by Arginine-Rich Cell-Penetrating Peptides in Rotifers , 2013, Marine Biotechnology.
[92] B. Wiesner,et al. Extensive cellular uptake into endothelial cells of an amphipathic β‐sheet forming peptide , 1997, FEBS letters.
[93] G. Bidwell,et al. Cell penetrating elastin-like polypeptides for therapeutic peptide delivery. , 2010, Advanced drug delivery reviews.
[94] M. Morris,et al. Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics , 2009, British journal of pharmacology.
[95] R. Lerner,et al. A cell-penetrating peptide from a novel pVII-pIX phage-displayed random peptide library. , 2002, Bioorganic & medicinal chemistry.
[96] Ülo Langel,et al. Design of a Tumor-Homing Cell-Penetrating Peptide , 2008 .
[97] F. Milletti,et al. Cell-penetrating peptides: classes, origin, and current landscape. , 2012, Drug discovery today.
[98] M. Giacca,et al. Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.
[99] Vladimir P Torchilin,et al. Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[100] Felix Kratz,et al. Cell penetrating peptides fused to a thermally targeted biopolymer drug carrier improve the delivery and antitumor efficacy of an acid-sensitive doxorubicin derivative. , 2012, International journal of pharmaceutics.
[101] R. Zhuo,et al. Construction of cell penetrating peptide vectors with N-terminal stearylated nuclear localization signal for targeted delivery of DNA into the cell nuclei. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[102] V. Torchilin,et al. “Smart” Drug Carriers: PEGylated TATp-Modified pH-Sensitive Liposomes , 2007, Journal of liposome research.
[103] P. Conti,et al. In Vivo Near-Infrared Fluorescence Imaging of Integrin α2β1 in Prostate Cancer with Cell-Penetrating-Peptide–Conjugated DGEA Probe , 2011, The Journal of Nuclear Medicine.
[104] Mark Bradley,et al. Peptides for cell-selective drug delivery. , 2012, Trends in pharmacological sciences.
[105] Vladimir P Torchilin,et al. Cell-penetrating peptides: breaking through to the other side. , 2012, Trends in molecular medicine.
[106] A. Jones,et al. Cell entry of cell penetrating peptides: tales of tails wagging dogs. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[107] M. Pooga,et al. The membrane repair response masks membrane disturbances caused by cell‐penetrating peptide uptake , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[108] X. Xue,et al. Antisense inhibition of gene expression and growth in gram-negative bacteria by cell-penetrating peptide conjugates of peptide nucleic acids targeted to rpoD gene. , 2012, Biomaterials.
[109] Vladimir P Torchilin,et al. Enhanced transfection of tumor cells in vivo using “Smart” pH-sensitive TAT-modified pegylated liposomes , 2007, Journal of drug targeting.
[110] E. Ruoslahti,et al. Molecular specialization of breast vasculature: A breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[111] J. Tam,et al. Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7. , 2002, Biochemistry.
[112] Jeong Yu Lee,et al. Intracellular delivery of paclitaxel using oil-free, shell cross-linked HSA--multi-armed PEG nanocapsules. , 2011, Biomaterials.
[113] G. Verdine,et al. An All-Hydrocarbon Cross-Linking System for Enhancing the Helicity and Metabolic Stability of Peptides , 2000 .
[114] Xiang-gao Meng,et al. The effect of a nuclear localization sequence on transfection efficacy of genes delivered by cobalt(II)-polybenzimidazole complexes. , 2012, Biomaterials.
[115] R. Brock,et al. Biological responses towards cationic peptides and drug carriers. , 2011, Trends in pharmacological sciences.
[116] A. Panitch,et al. Thermosensitive nanoparticles with pH-triggered degradation and release of anti-inflammatory cell-penetrating peptides. , 2012, Biomacromolecules.
[117] A. Zureikat,et al. Targeted therapy for solid tumors: current status. , 2008, Surgical oncology clinics of North America.
[118] P. Hammond,et al. Controlling in vivo stability and biodistribution in electrostatically assembled nanoparticles for systemic delivery. , 2011, Nano letters.
[119] You Han Bae,et al. TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[120] M. Giacca,et al. Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules. , 2005, The Biochemical journal.
[121] W. Hennink,et al. Delivery of Nucleic Acids , 2007, Pharmaceutical Research.
[122] Weijun Su,et al. CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma. , 2012, Biomaterials.
[123] A. Kuliopulos,et al. Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[124] Astrid Gräslund,et al. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides. , 2012, Accounts of chemical research.
[125] E. Giralt,et al. Proline-rich, amphipathic cell-penetrating peptides. , 2008, Advanced drug delivery reviews.
[126] R. Brasseur,et al. A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[127] Jianping Zhou,et al. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel. , 2012, Biomaterials.
[128] G. Bidwell,et al. Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin. , 2007, Biochemical pharmacology.
[129] E. Giralt,et al. Amphipathic peptides and drug delivery. , 2004, Biopolymers.
[130] Ű. Langel,et al. Cell membrane translocation of the N-terminal (1-28) part of the prion protein. , 2002, Biochemical and biophysical research communications.
[131] M. Ratnam,et al. The folate receptor: What does it promise in tissue-targeted therapeutics? , 2007, Cancer and Metastasis Reviews.